| Regulation of endothelium-derived nitric oxide production by the protein kinase Akt D Fulton, JP Gratton, TJ McCabe, J Fontana, Y Fujio, K Walsh, TF Franke, ... Nature 399 (6736), 597-601, 1999 | 3112 | 1999 |
| Biological action of leptin as an angiogenic factor MR Sierra-Honigmann, AK Nath, C Murakami, G Garcıa-Cardena, ... Science 281 (5383), 1683-1686, 1998 | 1944 | 1998 |
| Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. A Papapetropoulos, G García-Cardeña, JA Madri, WC Sessa The Journal of clinical investigation 100 (12), 3131-3139, 1997 | 1514 | 1997 |
| Dynamic activation of endothelial nitric oxide synthase by Hsp90 G García-Cardeña, R Fan, V Shah, R Sorrentino, G Cirino, ... Nature 392 (6678), 821-824, 1998 | 1327 | 1998 |
| Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway A Papapetropoulos, D Fulton, K Mahboubi, RG Kalb, DS O'Connor, F Li, ... Journal of Biological Chemistry 275 (13), 9102-9105, 2000 | 991 | 2000 |
| Hydrogen sulfide is an endogenous stimulator of angiogenesis A Papapetropoulos, A Pyriochou, Z Altaany, G Yang, A Marazioti, Z Zhou, ... Proceedings of the National Academy of Sciences 106 (51), 21972-21977, 2009 | 985 | 2009 |
| Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer C Szabo, C Coletta, C Chao, K Módis, B Szczesny, A Papapetropoulos, ... Proceedings of the National Academy of Sciences 110 (30), 12474-12479, 2013 | 761 | 2013 |
| Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation C Coletta, A Papapetropoulos, K Erdelyi, G Olah, K Módis, P Panopoulos, ... Proceedings of the National Academy of Sciences 109 (23), 9161-9166, 2012 | 747 | 2012 |
| Direct actions of angiopoietins-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors A Papapetropoulos, G García-Cardeña, TJ Dengler, PC Maisonpierre, ... Lab. Invest 79, 213-223, 1999 | 543 | 1999 |
| The concise guide to pharmacology 2019/20: Enzymes SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British Journal of Pharmacology 176, S297-S396, 2019 | 539 | 2019 |
| Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat V Shah, M Toruner, F Haddad, G Cadelina, A Papapetropoulos, K Choo, ... Gastroenterology 117 (5), 1222-1228, 1999 | 445 | 1999 |
| Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages A Xagorari, A Papapetropoulos, A Mauromatis, M Economou, T Fotsis, ... Journal of Pharmacology and Experimental Therapeutics 296 (1), 181-187, 2001 | 431 | 2001 |
| Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE) A Asimakopoulou, P Panopoulos, CT Chasapis, C Coletta, Z Zhou, ... British journal of pharmacology 169 (4), 922-932, 2013 | 424 | 2013 |
| International union of basic and clinical pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors C Szabo, A Papapetropoulos Pharmacological reviews 69 (4), 497-564, 2017 | 411 | 2017 |
| Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity M Bucci, A Papapetropoulos, V Vellecco, Z Zhou, A Pyriochou, C Roussos, ... Arteriosclerosis, thrombosis, and vascular biology 30 (10), 1998-2004, 2010 | 394 | 2010 |
| The concise guide to pharmacology 2021/22: Enzymes SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British journal of pharmacology 178, S313-S411, 2021 | 379 | 2021 |
| Intramitochondrial hydrogen sulfide production by 3‐mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics K Módis, C Coletta, K Erdélyi, A Papapetropoulos, C Szabo The FASEB Journal 27 (2), 601-611, 2013 | 342 | 2013 |
| European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) J Egea, I Fabregat, YM Frapart, P Ghezzi, A Görlach, T Kietzmann, ... Redox biology 13, 94-162, 2017 | 331 | 2017 |
| Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function K Suzuki, G Olah, K Modis, C Coletta, G Kulp, D Gerö, P Szoleczky, ... Proceedings of the National Academy of Sciences 108 (33), 13829-13834, 2011 | 326 | 2011 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 315 | 2017 |